Summit Therapeutics Inc Forecast and Target Price

Currently 7 wall-street analysts regularly analyze the financials of Summit Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 7 analysts offering 12-month price forecasts for Summit Therapeutics Inc (SMMT) have a share price target of $35. This median of share price forecast represents a 35.1% upside from the latest price of $25.91 as on 12.07.25.

Below is a chart showing the percentage difference between Summit Therapeutics Inc's share price and its median forecast price. As on 12.07.25, the difference is -39.44%